4
Changes in Ownership
OCULAR THERAPEUTIX, INC Filed Acc 0001104659-26-019802
Chief Strategy Officer sold 1,759 shares at $8.28 ($14,565)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nayak Sanjay Chief Strategy Officer | 2026-02-23 | Sale 10b5-1 | −1,759 | $8.28 | $14,565 | 330,653 | D: show line 1 in the form |
| Open-market sales · 1,759 sh · avg $8.28 · $14,565 | |||||||
Loading xslF345X05/tm267255-1_4seq1.xml…